Newsroom

BOULDER, Colo.--(BUSINESS WIRE)--ParaScript announced it has been named Embedded Technology Partner of the Year by Tungsten Automation, including an extended partnership....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 27.07.2026 FJAN.LN IE000MDKBOB3  150,002.00 USD   4,324,919.42   28.832  ...

RIDGEWOOD, N.J.--(BUSINESS WIRE)--Scale, a leading vertically-integrated provider of advanced energy solutions backed by EQT, today announced the hiring of David Vickerman as Chief Financial Officer. In this role, Vickerman will lead and manage all finance, accounting, and capital markets functions across Scale's two core business lines: Commercial & Industrial (C&I) and Data Center Solutions. His hire comes at a key inflection point for the company, which is experiencing tremendous gro...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 27.07.2026 H2O LN IE000Q8F0M81  600,002.00 USD  12,183,259.22   20.305  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 27.07.2026 GNOV LN IE000OJ31JQ4 1,000,002.00 USD 36,922,053.71 36.922  ...

LAUSANNE, Schweiz & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics SA, ein Biotechnologieunternehmen im klinischen Stadium, das Pionierarbeit im Bereich präziser, RNA-gesteuerter Therapeutika leistet, die auf das regulatorische Genom abzielen, um krankheitsauslösende Zellzustände bei häufigen, chronischen und altersbedingten Erkrankungen umzuprogrammieren, gab bekannt, dass die US-amerikanische Arzneimittelbehörde (FDA) für HTX-001 den „Fast-Track“-Status zur Behandlung der symptomatischen nicht...

PASADENA, Calif.--(BUSINESS WIRE)--Wescom Financial, a leading member-owned financial institution serving over 250,000 individuals in Southern and Central California, is proud to announce it has been Certified™ by Great Place To Work® for the fourth consecutive year, earning the prestigious workplace recognition in 2023, 2024, 2025 and now 2026. The certification is based entirely on feedback from current employees and recognizes organizations that create an exceptional workplace culture built...

LAUSANNE, Suisse & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics SA, une société de biotechnologie au stade clinique pionnière dans le domaine des thérapies de précision guidées par l’ARN qui ciblent le génome régulateur afin de reprogrammer les états cellulaires à l’origine de maladies courantes, chroniques et liées à l’âge, a annoncé que la Food and Drug Administration (FDA) américaine avait accordé la désignation Fast Track à HTX-001 pour le traitement de la cardiomyopathie hypertrophique no...

LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--The FDA has granted HAYA Therapeutics Fast Track Designation for HTX-001 for the treatment of symptomatic nonobstructive hypertrophic cardiomyopathy....